Group 1 - Shanghai Hantong Medical Technology Co., Ltd. recently completed a "Pre-A+ round" financing, raising several tens of millions of RMB, with Shuncheng Capital as the investor [1] - The company was established in 2022, has a registered capital of 5.105429 million RMB, and is primarily engaged in research and experimental development [1] - The company has invested in 5 other enterprises and holds 30 trademark registrations and 26 patents, along with 4 administrative licenses [1] Group 2 - The legal representative of Shanghai Hantong Medical Technology Co., Ltd. is Zhao Wanjin, and the company is located in Shanghai [1] - The shareholders include Zhao Wanjin, Hunan Dacheng Caizhi SME Venture Capital Partnership, Beijing Tongchuang Shared Medical Equity Investment Fund Partnership, Shanghai Hanmai Cheng Medical Technology Partnership, and Shanghai Hanmai Rong Medical Technology Partnership [1]
上海汉通医疗科技有限公司获“Pre-A+轮”融资,金额数千万人民币
Sou Hu Cai Jing·2025-08-25 04:48